Independent cancer second opinion for patients in the Netherlands and the Nordics
For patients in the Netherlands, Sweden, Denmark, Norway, Finland and Iceland. Kim reviews molecular reports and searches EU and US trials that fit your results.
What Kim reviews
- Pathology and tumor profiling (NGS) reports, including FoundationOne, Caris, Tempus and Guardant360
- Signatera and other ctDNA results
- Clinical trials that fit your molecular profile, locally and internationally
- Written questions and evidence your oncologist can act on
Price and scheduling
Every engagement starts with a free 15-minute call. No records or payment needed, and no obligation. The Clarity Report is USD $2,000 (about €1,870). Active Case Management: $4,500 / month; Concierge Advisory: $7,500 / month.
Video calls in CET / EET. Paid receipts are suitable for supplementary private policies and international insurance where out-of-network specialist review is covered.
All fees are in US dollars and payable online by card. Calls are scheduled to fit your time zone. Records in languages other than English may require translation before review.
Calls are with Kim Lockheimer, PhD, DFM, Chief Scientific Officer. Prices in local currency: /nl/pricing.
Advisory only: diagnosis and treatment stay with your treating oncologist.
Guides for patients
- FoundationOne report explained
- How to read Signatera test results
- Focused Report Review: one report, one question